James Campbell

Disclosure(s): GSK: Grant/Research Support; Merck: Grant/Research Support; Moderna: Grant/Research Support; Pfizer: Grant/Research Support; Sanofi: Grant/Research Support

Presentation(s):

• 225 - The Immunology and Safety of Maternal RSV Vaccination, Infant Nirsevimab Immunization, or Both Products- Interim Analysis of a Randomized Clinical Trial

  Monday, October 20, 2025
  3:27 PM - 3:39 PM US ET

• 168 - What’s Old Is New: Vaccine-Preventable Diseases

  Tuesday, October 21, 2025
  1:45 PM - 3:00 PM US ET

• 428 - What's This Rash?

  Tuesday, October 21, 2025
  2:10 PM - 2:35 PM US ET